Weight Loss Guide • The Care Pharmacy
Mounjaro Reviews: What are Patients Really Saying and Does It Live Up to the Hype?
A balanced review of what Mounjaro patients are really saying, covering positive experiences, common side effects, weight loss results, and how it compares to Wegovy.
Explore Weight Loss Treatment at The Care Pharmacy
Patient reviews of Mounjaro tell a story that clinical trial data alone cannot — what it actually feels like to inject tirzepatide once a week, how appetite changes in practice, which side effects are genuinely disruptive, and whether the weight loss results match the remarkable numbers published in the SURMOUNT trials. The headline figures are compelling: average weight loss of up to 20.9% of body weight at the highest dose over 72 weeks. But behind those averages are thousands of individual patient experiences that vary considerably depending on dose, diet, lifestyle, and how well-prepared patients were before starting treatment. Patient reviews of Mounjaro are overwhelmingly positive — but they are not uniformly so, and the negative experiences that do appear in the review landscape are almost always explainable by factors that a thorough clinical consultation and proper patient education can address. At The Care Pharmacy, our prescribing team supports patients throughout their Mounjaro journey — not just at the point of prescribing, but at every stage of treatment where questions arise and reassurance is needed.
Every question about Mounjaro treatment deserves a clear and clinically informed answer — get in touch with our team, or complete our online consultation to find out whether Mounjaro is right for you.
Start Your Consultation
Quick Answer
Mounjaro reviews are predominantly positive — patients most commonly report significant appetite suppression, meaningful weight loss, and an experience that feels qualitatively different from previous weight loss attempts. The most frequently reported challenges are gastrointestinal side effects during the dose escalation phase — particularly nausea, constipation, and fatigue — which most patients find manageable and which typically settle as the body adjusts. Patients who prepare well before starting treatment, maintain adequate protein intake, stay hydrated, and engage with clinical support throughout tend to report significantly better experiences than those who start the medication without adequate preparation or ongoing guidance. Negative Mounjaro reviews are most commonly linked to unrealistic expectations, inadequate dietary adjustment, or side effects that were not anticipated — all of which are largely addressable through proper clinical preparation. The clinical evidence and patient experience data together make Mounjaro the most consistently well-reviewed prescription weight loss medication currently available in the UK.
What Do Mounjaro Reviews Generally Say?
Across the major UK review platforms, patient forums, and social media communities where Mounjaro users share their experiences, several consistent themes emerge regardless of the source.
The most commonly reported positive themes in Mounjaro reviews:
- Dramatically reduced appetite: The most universally reported experience across positive reviews is a profound reduction in appetite — patients describe feeling full after small amounts of food, losing interest in snacking, and no longer experiencing the intrusive food cravings that had previously made caloric restriction so difficult to sustain
- Significant and consistent weight loss: The majority of positive reviews report consistent, weekly weight loss that patients describe as unlike anything they have experienced with diet alone — with many noting that they are achieving results they had previously considered impossible
- Improved relationship with food: A recurring theme in longer-term reviews is a qualitative shift in the patient’s relationship with food — reduced emotional eating, greater satisfaction from smaller portions, and a feeling of being in control of food choices rather than driven by hunger
- Improved energy and confidence: As weight loss accumulates, patients frequently report improvements in energy levels, mobility, self-confidence, and mood — changes that go beyond the physical and reflect the broader health benefits of sustained weight reduction
- Convenience of once-weekly dosing: The once-weekly injection schedule is consistently praised in reviews — patients find it easy to incorporate into their routine and appreciate not having to remember daily medication
The most commonly reported negative themes:
- Nausea and gastrointestinal discomfort, particularly in the first few weeks at each new dose level
- Constipation — more commonly reported in Mounjaro reviews than nausea, and often underestimated by patients before starting
- Fatigue in the first days after each weekly injection
- Hair thinning — reported by a proportion of patients, typically associated with rapid weight loss rather than the medication itself
- The cost of ongoing treatment, particularly for patients not in a position to claim any NHS support
Why So Many Patients Have Positive Experiences
The consistency of positive Mounjaro reviews is not accidental — it reflects both the genuine clinical efficacy of tirzepatide and several characteristics of the patients who tend to engage most successfully with treatment.
Patients who report the best Mounjaro experiences almost always share certain behavioural and attitudinal characteristics:
- They treat Mounjaro as a tool, not a solution. The most successful patients use the appetite suppression that Mounjaro provides as a window of opportunity to build sustainable dietary habits — increasing protein intake, reducing ultra-processed food, and establishing an exercise routine — rather than simply eating less of the same foods
- They prepare for the dose escalation phase. Patients who know in advance that nausea and fatigue are most likely in the first one to two weeks at each new dose level approach this period with significantly less anxiety and disruption than those who are caught off guard
- They stay well hydrated. Mounjaro reduces thirst signals in many patients — a consequence of appetite suppression — and inadequate hydration worsens nausea, constipation, and fatigue considerably. Patients who make a deliberate effort to maintain fluid intake consistently report better tolerability
- They prioritise protein intake. One of the most clinically important dietary adjustments during Mounjaro treatment is ensuring adequate protein consumption to preserve lean muscle mass as body weight reduces. Patients who address this proactively report better body composition outcomes and reduced fatigue
- They engage with clinical support when questions arise. Patients who feel supported throughout their treatment — who know where to turn when side effects concern them or when progress stalls — have a fundamentally different experience from those managing treatment in isolation
What Reviews Say About Side Effects
Side effects are the most discussed aspect of Mounjaro reviews after weight loss results — and the picture that emerges from patient accounts is more nuanced than clinical trial data alone conveys.
Nausea
Nausea is the most frequently mentioned side effect in Mounjaro reviews and the one that most commonly prompts patients to consider stopping treatment. Patient accounts are consistent in noting that nausea is most pronounced in the first one to two weeks at each new dose level and typically subsides significantly as the body adjusts. Reviews from patients who persisted through the initial nausea almost universally describe it as manageable in retrospect — and most describe the dose escalation phase becoming progressively easier with each step up.
Practical strategies consistently mentioned in patient reviews for managing Mounjaro nausea:
- Eating small, frequent meals rather than large ones
- Avoiding rich, fatty, or very spicy foods during the first days at each new dose
- Injecting in the evening so that peak nausea coincides with sleep
- Staying well hydrated throughout the day
- Ginger tea or ginger supplements, which many patients report as helpful for mild nausea
Constipation
Constipation is arguably the most underreported Mounjaro side effect in pre-treatment patient information and the one that most surprises patients once they start. The slowed gastric emptying that is central to Mounjaro’s weight loss mechanism also slows transit throughout the digestive system, and reduced food intake compounds this effect. Patient reviews consistently recommend proactive management — increasing fibre intake, maintaining hydration, and gentle exercise — rather than waiting for constipation to become severe.
Fatigue
Fatigue in the first twenty-four to forty-eight hours after each injection is reported by a significant proportion of patients, particularly in the earlier stages of treatment. Most reviews describe this as a mild and temporary effect that diminishes significantly as treatment continues. Planning injections for days when physical demands are lower is a commonly shared practical approach in patient communities.
Hair thinning
Hair thinning is mentioned in a proportion of Mounjaro reviews, typically appearing several months into treatment during a period of rapid weight loss. This is clinically understood as telogen effluvium — a temporary stress response of the hair cycle triggered by rapid weight loss rather than by tirzepatide itself — and most patients who experience it report that shedding slows and reverses as their rate of weight loss stabilises.

What Reviews Say About Weight Loss Results
The weight loss results reported in patient Mounjaro reviews are, for the majority of patients, genuinely impressive — and broadly consistent with what clinical trial data would predict for a real-world population.
Common patterns in patient weight loss accounts:
- Rapid initial response: Many patients report noticeable appetite suppression and initial weight loss within the first one to two weeks at the starting dose, which creates early positive momentum that patients describe as motivating
- Progressive improvement with dose escalation: Reviews consistently note that weight loss accelerates as doses increase — with many patients describing the step from 5mg to 7.5mg and beyond as producing a noticeably stronger appetite-suppressing effect
- Plateaus are common and normal: A proportion of patient reviews describe periods of slower progress, particularly around certain dose levels or following periods of social eating and holidays. These are normal parts of a non-linear weight loss trajectory and do not indicate that the medication has stopped working
- Results are dose-dependent: Patients on higher doses consistently report greater weight loss than those on lower doses — consistent with the dose-dependent outcomes observed in the SURMOUNT-1 trial data
Get in touch with our prescribing team if you have questions about what results are realistic for your circumstances, or complete our online consultation to get started.
Why Some Patients Struggle — and What Usually Explains It
Negative Mounjaro reviews are less common than positive ones, but they follow consistent patterns that are worth examining — because most of the experiences described in negative reviews are not inherent failures of the medication but outcomes that are largely avoidable with the right preparation and support.
The most common patterns in negative Mounjaro reviews:
- Stopping during dose escalation: A significant proportion of negative reviews come from patients who stopped treatment during the most challenging phase — the first few weeks at each new dose level — before the side effects had time to settle. Clinical support and realistic expectation-setting before starting treatment substantially reduces early discontinuation.
- Inadequate dietary adjustment: Patients who do not meaningfully change their diet during Mounjaro treatment — continuing to eat high-fat, ultra-processed foods but simply less of them — tend to achieve less weight loss and experience more side effects than those who use the appetite suppression to make qualitative dietary changes.
- Unrealistic expectations of speed: Some negative reviews reflect frustration that weight loss is not faster, despite results being clinically meaningful. Mounjaro produces significant weight loss over months and years — not days — and patients who approach treatment with patience and a long-term perspective consistently report better experiences.
- Insufficient clinical support: Patients who feel unsupported during treatment — who have questions about their side effects or their progress but do not know where to turn — are significantly more likely to discontinue prematurely and report a negative overall experience.
Context makes all the difference when it comes to managing expectations on Mounjaro. See what your personalised weight loss potential could look like by entering your details into the calculator below:
Mounjaro vs Wegovy: What Patient Reviews Reveal
Many patients who have tried both Mounjaro and Wegovy offer comparative reviews that are clinically informative — and the pattern that emerges is largely consistent with the clinical trial data.
| Feature |
Mounjaro (tirzepatide) |
Wegovy (semaglutide) |
| Average weight loss (trials) |
Up to 20.9% of body weight |
14.9% of body weight |
| Appetite suppression (patient reports) |
Described as stronger by most switchers |
Significant — well established |
| Nausea (patient reports) |
Common during escalation — settles with time |
Common during escalation — similar profile |
| Oral option available |
No — injection only |
Yes — oral tablet now MHRA-approved |
| Overall patient satisfaction |
Very high — particularly for weight loss outcomes |
High — strong track record and real-world evidence |
| Best suited to |
Patients prioritising maximum weight loss |
Patients preferring oral option or longer track record |
The most consistent finding in comparative reviews is that patients who switch from Wegovy to Mounjaro report stronger appetite suppression and greater weight loss — broadly consistent with the clinical trial data showing Mounjaro’s superior average efficacy. However, patient reviews also reflect that some individuals respond better to semaglutide than tirzepatide — individual biological variation means that the medication with the highest average efficacy is not always the best fit for every patient. A clinical consultation remains the most reliable way to identify the most appropriate starting point for your individual circumstances.
Is Mounjaro Worth It? An Honest Assessment
Synthesising the clinical evidence and the consistent patterns in patient reviews, the honest assessment of Mounjaro is that it is — for the right patient, with the right preparation and support — the most effective weight loss medication currently available in the UK.
Mounjaro is worth it if:
- Maximising weight loss is your primary goal and you are prepared to invest in the dietary and lifestyle changes that make the medication most effective
- You have struggled with diet-only approaches and want the appetite suppression that tirzepatide provides to create a genuine caloric deficit without the constant hunger that accompanies restriction alone
- You are comfortable with a weekly injection and willing to persist through the dose escalation phase, knowing that side effects typically improve significantly after the first few weeks at each new dose
- You have access to clinical support — through your prescriber or prescribing pharmacy — to answer questions and provide guidance when challenges arise
- You approach treatment with realistic expectations: significant, meaningful weight loss over months rather than dramatic results in weeks
Mounjaro may not be the right starting point if:
- You have a contraindication — including a personal or family history of medullary thyroid carcinoma, MEN2, or pancreatitis — that makes tirzepatide clinically inappropriate
- You are strongly averse to injections and would prefer an oral alternative — in which case the Wegovy oral tablet is worth discussing with your prescriber
- You are not in a position to make any dietary or lifestyle changes alongside the medication — results are significantly better in patients who engage with the behavioural aspects of treatment alongside the pharmacological support

Frequently Asked Questions
From real patient experiences to what results are realistic, here are the questions our prescribing team is asked most often about Mounjaro:
Are Mounjaro reviews generally positive?
Yes — the overwhelming pattern in Mounjaro reviews across UK review platforms and patient communities is strongly positive, with patients most commonly reporting significant appetite suppression, consistent weight loss, and an experience that compares favourably to previous weight loss attempts. Negative reviews exist but follow identifiable patterns — most commonly related to side effects during dose escalation that were not adequately anticipated, or to insufficient dietary and lifestyle adjustment alongside the medication.
How quickly do patients notice results on Mounjaro?
Most patients report noticeable appetite suppression within the first one to two weeks of starting Mounjaro, with initial weight loss typically becoming apparent within the first month at the starting dose. Weight loss accelerates progressively as doses increase during the escalation phase, with the most significant changes typically reported between three and six months into treatment.
What do patients say about Mounjaro side effects?
The most commonly discussed side effects in patient reviews are nausea and constipation during the dose escalation phase, followed by fatigue in the first day or two after each injection — with the majority of patients describing these as manageable and temporary rather than treatment-limiting. Patients who prepare in advance for the escalation phase and who take practical steps to manage nausea and constipation proactively consistently report significantly better tolerability than those who are caught off guard.
Do Mounjaro results last after stopping treatment?
Clinical evidence and patient accounts both indicate that a proportion of patients regain weight after stopping Mounjaro, as the appetite-suppressing effects of tirzepatide are no longer present — this is why the treatment period is best used to embed sustainable dietary and lifestyle habits that can maintain results after treatment ends. Patients who have successfully changed their relationship with food during treatment typically maintain a greater proportion of their weight loss than those who rely solely on the pharmacological appetite suppression without making broader behavioural changes.
How does Mounjaro compare to Wegovy in patient reviews?
Patients who have tried both medications most commonly report that Mounjaro produces stronger appetite suppression and greater weight loss — consistent with the clinical trial data showing tirzepatide’s superior average efficacy over semaglutide. However, individual responses vary and some patients find Wegovy better tolerated or equally effective for their circumstances — a clinical consultation is the most reliable way to determine the most appropriate starting point.
Is Mounjaro worth the cost for weight loss?
Patient reviews consistently reflect that those who achieve significant weight loss on Mounjaro regard the investment as worthwhile — particularly when framed against the cost of obesity-related health conditions, the impact on quality of life, and the comparison with surgical alternatives. The most meaningful way to assess value is through a clinical consultation that establishes realistic expectations for your individual starting point and circumstances.
Mounjaro and the Right Support
Mounjaro reviews tell a consistent story: when patients are well-prepared, clinically supported, and approach treatment with realistic expectations and genuine dietary engagement, the results are remarkable. The clinical trial data and the real-world patient experience converge on the same conclusion — tirzepatide is the most effective weight loss medication currently available in the UK, and the majority of patients who use it correctly are glad they did.
Patients who get the most from Mounjaro are not simply those who inject once a week and wait. They are those who use the appetite suppression the medication provides to make the dietary and lifestyle changes that produce lasting results — and who have access to clinical support when the inevitable questions, plateaus, and challenges arise during the course of treatment.
At The Care Pharmacy, our pharmacist-led prescribing team is here to provide exactly that support — from your initial consultation and first prescription through to dose reviews, side effect guidance, and the longer-term management of your treatment. Whether you are considering Mounjaro for the first time or want to know whether it is the right fit for your circumstances, our team is here to help.
A clearer answer is closer than you think — get in touch with our prescribing team, or complete our online consultation to find out whether Mounjaro is right for you.
Find out if Mounjaro is right for you
Begin a free, confidential online consultation with our pharmacist-led team. Mounjaro and other prescription weight loss treatments available following clinical assessment.
Start Your Consultation
This article was written by Pharmacy Mentor and clinically reviewed by Mohammed Ismail Lakhi, MPharm, MRPharm, Superintendent Pharmacist at The Care Pharmacy. Mohammed is registered with the General Pharmaceutical Council (GPhC registration number 2072815) and leads clinical governance across The Care Pharmacy’s weight management services.
Last reviewed: August 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.